关于 Rivaroxaban
- 原研厂家
- Bayer Healthcare Pharmaceuticals Inc.; Johnson & Johnson Pharmaceutical Research & Development Llc
- 适应症
- Pulmonary Embolism; Stroke; Congenital Heart Defect; Thrombosis; Coronary Artery Disease; Coronary Artery Lesion; Peripheral Arterial Disease; Atherosclerosis; Venous Thrombosis; Embolism; Venous Thromboembolism
- 获批日期
- 09/30/2008
- DS/DP
- 08/28/2024
可供应中间体
当前列出 Rivaroxaban 的 7 个中间体。可就下方任一产品索取规格、文件或报价。
| 产品名称 | CAS 号 | 分子式 | 物理性质 |
|---|---|---|---|
| 4-(4-Aminophenyl)morpholin -3-one | 438056-69-0 | / | / |
| (S)-(+)-N-(2,3-Epoxypropyl)phthalimide | 161596-47-0 | / | / |
| 5-Chlorothiophene-2-carboxylic acid | 24065-33-6 | / | / |
| 5-Chlorothiophene-2-carbonyl chloride | 42518-98-9 | / | / |
| 2-[[(5S)-2-0x0-3-[4-(3-0xo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione | 446292-08-6 | / | / |
| 4-[4-[(5S)-5-(Aminomethyl)-2-0xo-3-oxazolidinyl]phenyl] -3-morpholinone hydrochloride | 898543-06-1 | / | / |
| 2-[(2R)-2-Hydroxy-3-[[4-(3-oxo-4-Morpho linyl)phenyl]aMino]propyl]-1H-isoindole-1 ,3(2H)-dione | 446292-07-5 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →